Findings suggest “less is more” and “tried and true” may benefit select patients SAN DIEGO, Dec. 10, 2023 /PRNewswire/ — Research findings being presented at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition highlight new treatment approaches that are enabling patients to live longer or better, judicious uses of older treatment approaches,… Continue reading Studies Highlight Both Novel Treatments and Enduring Value of Older Approaches
Category: Newswire
FTCH DEADLINE NOTICE: ROSEN, A LEADING NATIONAL FIRM, Encourages Farfetch Limited Investors to Secure Counsel Before Important December 19 Deadline in Securities Class Action – FTCH
NEW YORK, Dec. 10, 2023 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Farfetch Limited (NYSE: FTCH) between March 9, 2023 and August 17, 2023, both dates inclusive (the “Class Period”), of the important December 19, 2023 lead plaintiff deadline. SO WHAT: If you purchased Farfetch Limited securities… Continue reading FTCH DEADLINE NOTICE: ROSEN, A LEADING NATIONAL FIRM, Encourages Farfetch Limited Investors to Secure Counsel Before Important December 19 Deadline in Securities Class Action – FTCH
Sanofi and Minapharm Sign an Exclusive Agreement for Localizing the manufacture of Clexane®
CAIRO and PARIS, Dec. 10, 2023 /PRNewswire/ — Sanofi and Minapharm announce the signing of an exclusive Manufacturing and Supply Agreement for the localization of the full range of its flagship market leader product, Clexane®. Continue Reading Sanofi and Minapharm Sign an Exclusive Agreement for Localizing the manufacture of Clexane® (PRNewsfoto/Minapharm Pharmaceuticals) The agreement between… Continue reading Sanofi and Minapharm Sign an Exclusive Agreement for Localizing the manufacture of Clexane®
ILLUMINA DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Illumina To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $100,000 investing in Illumina securities between May 1, 2023 and October 16, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/ILMN. There is no cost or obligation to… Continue reading ILLUMINA DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Illumina To Contact Him Directly To Discuss Their Options
BEAUTY HEALTH ONGOING DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Beauty Health To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $50,000 investing in Beauty Health securities between May 10, 2022 and November 13, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/SKIN. There is no cost or obligation… Continue reading BEAUTY HEALTH ONGOING DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Beauty Health To Contact Him Directly To Discuss Their Options
ADOBE ONGOING DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Adobe To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $100,000 investing in Adobe securities between July 23, 2021 and September 15, 2022 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/ADBE. There is no cost or obligation to… Continue reading ADOBE ONGOING DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Adobe To Contact Him Directly To Discuss Their Options
CHARGEPOINT DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In ChargePoint To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $50,000 investing in ChargePoint securities between June 1, 2023 and November 16, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/CHPT. There is no cost or obligation to… Continue reading CHARGEPOINT DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In ChargePoint To Contact Him Directly To Discuss Their Options
CAPSTONE DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Capstone To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $100,000 investing in Capstone securities between June 14, 2021 and September 22, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/CGRNQ. There is no cost or obligation to… Continue reading CAPSTONE DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Capstone To Contact Him Directly To Discuss Their Options
DERMTECH ONGOING DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In DermTech To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $25,000 investing in DermTech stock or options between March 8, 2021 and November 3, 2022 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/DMTK. There is no cost or… Continue reading DERMTECH ONGOING DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In DermTech To Contact Him Directly To Discuss Their Options
CHARGEPOINT DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In ChargePoint To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $50,000 investing in ChargePoint securities between June 1, 2023 and November 16, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/CHPT. There is no cost or obligation to… Continue reading CHARGEPOINT DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In ChargePoint To Contact Him Directly To Discuss Their Options